Molecular and cellular genetics of fragile X syndrome
1999; Wiley; Volume: 88; Issue: 1 Linguagem: Inglês
10.1002/(sici)1096-8628(19990205)88
ISSN1096-8628
AutoresWalter E. Kaufmann, Allan L. Reiss,
Tópico(s)RNA modifications and cancer
ResumoAmerican Journal of Medical GeneticsVolume 88, Issue 1 p. 11-24 Full Access Molecular and cellular genetics of fragile X syndrome Walter E. Kaufmann, Corresponding Author Walter E. Kaufmann [email protected] Departments of Pathology, Neurology, Pediatrics, and Psychiatry, Johns Hopkins University School of Medicine, Baltimore, Maryland522 Kennedy Krieger Institute, 707 N. Broadway, Baltimore, MD 21205Search for more papers by this authorAllan L. Reiss, Allan L. Reiss Division of Child and Adolescent Psychiatry and Child Development, Departments of Psychiatry and Pediatrics, Stanford University School of Medicine, Stanford, CaliforniaSearch for more papers by this author Walter E. Kaufmann, Corresponding Author Walter E. Kaufmann [email protected] Departments of Pathology, Neurology, Pediatrics, and Psychiatry, Johns Hopkins University School of Medicine, Baltimore, Maryland522 Kennedy Krieger Institute, 707 N. Broadway, Baltimore, MD 21205Search for more papers by this authorAllan L. Reiss, Allan L. Reiss Division of Child and Adolescent Psychiatry and Child Development, Departments of Psychiatry and Pediatrics, Stanford University School of Medicine, Stanford, CaliforniaSearch for more papers by this author First published: 24 October 2002 https://doi.org/10.1002/(SICI)1096-8628(19990205)88:1 3.0.CO;2-OCitations: 65AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES Abitbol M, Menini C, Delezoide, A-L, Rhyner, T, Vekemans, M, Mallet, J. 1993. Nucleus basalis magnocellularis and hippocampus are the major sites of FMR-1 expression in the human fetal brain. Nat Genet 4: 147–152. Abrams MT, Reiss AL. 1995. The neurobiology of fragile X syndrome. Ment Retard Dev Dis Res Rev 1: 269–275. Abrams MT, Reiss, A.L, Freund, LS, Baumgardner, TL, Chase, GA, Denckla, MB. 1994. Molecular-neurobehavioral associations in females with the fragile X full mutation. Am J Med Genet 51: 317–327. Abrams MT, Kaufmann WE, Rousseau F, Oostra BA, Wolozin B, Taylor CJ, Lishaa N, Morel, M-L, Hoogenveen, A, Reiss, AL. 1998. FMR1 gene expression in olfactory neuroblasts from two males with fragile X syndrome. Am J Med Genet (in press). Ashley CT, Sutcliffe JS, Kunst CB, Leiner HA, Eichler EE, Nelson DL, Warren ST. 1993a. Human and murine FMR-1: Alternative splicing and translational initiation downstream of the CGG-repeat. Nat Genet 4: 244–251. Ashley CTJ, Wilkinson KD, Reines D, Warren ST. 1993b. FMR1 protein: Conserved RNP family domains and selective RNA binding. Science 262: 563–566. Bakker C, Verheij C, Willemsen R, van der Helm, R, Oerlemans, F, Vermey, M, Bygrave, A, Hoogeveen, A, Oostra, B, Reyniers, E, De Boulle, K, D'Hooge, R, Cras, P, van Velzen, D, Nagels, G, Martin, J-J, De Deyn, PP, Darby, JK, Willems, PJ. 1994. Fmr1 knockout mice: A model to study fragile X mental retardation. Cell 78: 23–33. Beemer FA, Veenema H, de Pater, JM. 1986. Cerebral gigantism (Sotos syndrome) in two patients with fra(X) chromosomes. Am J Med Genet 23: 221–226. Bell MV, Hirst MC, Nakahori Y,et al. 1991. Physical mapping across the fragile X: Hypermethylation and clinical expression of the fragile X syndrome. Cell 64: 861–866. Berry KE, Sklena P. 1993. Demonstration of abnormal cyclic AMP production in platelets from patients with fragile X syndrome. Am J Med Genet 45: 81–87. Berry-Kravis, E, Hicar, M, Ciurlionis, R. 1995. Reduced cyclic AMP production in fragile X syndrome: Cytogenetic and molecular correlations. Pediatr Res 38: 638–643. Bird AP. 1987. CpG islands as gene markers in the vertebrate nucleus. Trends Genet 3: 342–347. Bird AP. 1992. The essentials of DNA methylation. Cell 70: 5–8. Brown WT, Jenkins EC, Friedman E, Brooks J, Wisniewski K, Raguthu S, French J. 1982. Autism is associated with the fragile-X syndrome. J Autism Dev Disord 12: 303–308. Brown WT, Houck, G Jr, Jeziorowska, A, Levinson, FN, Ding, X, Dobkin, C, Zhong, N, Henderson, J, Brooks, SS, Jenkins, EC. 1993. Rapid fragile X carrier screening and prenatal diagnosis using a nonradioactive PCR test. JAMA 270: 1569–1575. Comery TA, Harris JB, Willems PJ, Oostra BA, Irwin SA, Weiler IJ, Greenough WT. 1997. Abnormal dendritic spines in fragile X knockout mice: Maturation and pruning deficits. Proc Natl Acad Sci USA 94: 5401–5404. Cronister A, Schreiner R, Wittenberger M, Amiri K, Harris K, Hagerman RJ. 1991. Heterozygous fragile X female: Historical, physical, cognitive, and cytogenetic features. Am J Med Genet 38: 269–274. De Bouelle, K, Verkerk, AJ, Reyniers, E, Vits, L, Hendrickx, J, Van Roy, B, Van den Bos, F, de Graaff, E, Oostra, BA, Willems, PJ. 1993. A point mutation in the FMR-1 gene associated with fragile X mental retardation. Nat Genet 3: 31–35. de Graaff, E, Rouillard, P, Willems, PJ, Smits, AP, Rousseau, F, Oostra, BA. 1995a. Hotspot for deletions in the CGG repeat region of FMR1 in fragile X patients. Hum Mol Genet 4: 45–49. de Graaff, E, Willemsen, R, Zhong, N, de Die-Smulders, CEM, Brown, WT, Freling, G, Oostra, B. 1995b. Instability of the CGG repeat and expression of the FMR1 protein in a male fragile X patient with a lung tumor. Am J Hum Genet 57: 609–618. de Vries, BB, Niermeijer, MF. 1994. The Prader-Willi-like phenotype in fragile X patients: A designation facilitating clinical (and molecular) differential diagnosis. J Med Genet 31: 260–261. de Vries, BBA, Wiegers, AM, Smits, APT, Mohkamsing, S, Duivenvoorden, HJ, Fryns, J-P, Curfs, LMG, Halley, DJJ, Oostra, BA, van den Ouweland, AMW, Niermeijer, MF. 1996. Mental status of females with an FMR1 gene full mutation. Am J Hum Genet 58: 1025–1032. Devys D, Biancalana V, Rousseau F, BouÄ, J, Mandel, JL, Oberlé, I. 1992. Analysis of full fragile X mutations in fetal tissues and monozygotic twins indicate that abnormal methylation and somatic heterogeneity are established early in development. Am J Med Genet 43: 208–216. Devys D, Lutz Y, Rouyer N, Bellocq, J-P, Mandel, J-L. 1993. The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation. Nat Genet 4: 335–340. Eberhart D, Malter H, Feng Y, Warren S. 1996. The fragile X mental retardation protein contains both nuclear localization and nuclear export signals. Hum Mol Genet 5: 1083–1091. Eichler EE, Richards S, Gibbs RA, Nelson DL. 1993. Fine structure of the human FMR1 gene. Hum Mol Genet 2: 1147–1153. Feng Y, Lakkis L, Devys D, Warren ST. 1995a. Quantitative comparison of FMR1 gene expression in normal and premutation alleles. Am J Hum Genet 56: 106–113. Feng Y, Zhang F, Lokey L, Chastain J, Lakkis L, Eberhart D, Warren S. 1995b. Translational suppression by trinucleotide repeat expansion at FMR1. Science 268: 731–734. Feng Y, Gutekunst, C-A, Eberhart, DE, Yi, H, Warren, ST, Hersch, SM. 1997. Fragile X mental retardation protein: Nucleocytoplasmic shuttling and association with somatodendritic ribosomes. J Neurosci 17: 1539–1547. Fisch GS. 1992. Is autism associated with the fragile X syndrome? Am J Med Genet 43: 47–55. Fisch GS. 1993. What is associated with the fragile X syndrome? Am J Med Genet 48: 112–121. Freund LS, Reiss AL, Abrams MT. 1993. Psychiatric disorders associated with fragile X in the young female. Pediatrics 91: 321–329. Fu YH, Kuhl DP, Pizzuti A, Pieretti M, Sutcliffe JS, Richards S, Verkerk AJ, Holden JJ, Fenwick, RG Jr, Warren, ST, Oostra, BA, Nelson, DL, Caskey, CT. 1991. Variation of the CGG repeat at the fragile X site results in genetic instability: Resolution of the Sherman paradox. Cell 67: 1047–1058. Gedeon AK, Baker E, Robinson H, Partington MW, Gross B, Manca A, Korn B, Poustka A, Yu S, Sutherland GR, Mulley JC. 1992. Fragile X syndrome without CCG amplification has an FMR1 deletion. Nat Genet 1: 341–344. Glover TW. 1981. FUdR induction of the X chromsome fragile site: Evidence for the mechanism of folic acid and thymidine inhibition. Am J Hum Genet 33: 234–242. Graham, JM Jr., Hoehn, H, Lin, MS, Smith, DW. 1981. Diploid-triploid mixoploidy: Clinical and cytogenetic aspects. Pediatrics 68: 23–28. Gustavson KH, Blomquist HK, Holmgren G. 1986. Prevalence of the fragile-X syndrome in mentally retarded boys in a Swedish county. Am J Med Genet 23: 581–587. Hagerman RJ. 1991. Physical and behavioral phenotype. In: RJ Hagerman, AC Silverman, editors: Fragile X syndrome: Diagnosis, treatment and research. Baltimore: Johns Hopkins University Press. pp 3–68. Hagerman RJ, Sobesky WE. 1989. Psychopathology in fragile X syndrome. Am J Orthopsychiatry 59: 142–152. Hagerman RJ, Jackson C, Amiri K, Silverman AC, O'Connor, R, Sobesky, W. 1992. Girls with fragile X syndrome: Physical and neurocognitive status and outcome. Pediatrics 89: 395–400. Hagerman RJ, Hull CE, Safanda JF, Carpenter I, Staley LW, O'Connor, RA, Seydel, C, Mazzocco, MM, Snow, K, Thibodeau, SN. 1994. High functioning fragile X males: Demonstration of an unmethylated fully expanded FMR-1 mutation associated with protein expression. Am J Med Genet 51: 298–308. Hansen RS, Gartler SM, Scott CR, Chen, S-H, Laird, CD. 1992. Methylation analysis of CGG sites in the CpG island of the human FMR1 gene. Hum Mol Genet 1: 571–578. Hanzhk AJ, Osemlak HM, Hauser MA, Kurnit DM. 1993. A recombination-based assay demonstrates that the fragile X sequence is transcribed widely during development. Nat Genet 3: 44–48. Harrison CJ, Jack EM, Allen TD, Harris R. 1983. The fragile X: A scanning electron microscope study. J Med Genet 20: 280–285. Heitz D, Rousseau F, Devys D, Saccone S, Abderrahim H, Le Paslier, D, Cohen, D, Vincent, A, Toniolo, D, Delia Valle, G. 1991. Isolation of sequences that span the fragile X and identification of a fragile X-related CpG island. Science 251: 1236–1239. Heitz D, Devys D, Imbert G, Kretz C, Mandel JL. 1992. Inheritance of the fragile X syndrome: Size of the fragile X premutation is a major determinant of the transition to full mutation. J Med Genet 29: 794–801. Hergersberg M, Matsuo K, Gassmann M, Schaffner W, Luscher B, Rulicke T, Aguzzi A. 1995 Tissue-specific expression of a FMR1/beta-galactosidase fusion gene in transgenic mice. Hum Mol Genet 4: 359–366. Hinds HL, Ashley CT, Sutcliffe JS, Nelson DL, Warren ST, Housman DE, Schalling M. 1993. Tissue specific expression of FMR-1 provides evidence for a functional role in fragile X syndrome. Nat Genet 3: 36–43. Hinton VJ, Brown WT, Wisniewski K, Rudelli RD. 1991. Analysis of neocortex in three males with the fragile X syndrome. Am J Med Genet 41: 289–294. Hirst MC, Roche A, Flint TJ,et al. 1991. Linear order of new and established DNA markers around the fragile site at Xq27.3. Genomics 10: 243–249. Hirst MC, Grewal P, Flannery A, Slatter R, Maher E, Barton D, Fryns JP, Davies K. 1995. Two new cases of FMR1 deletion associated with mental impairment. Am J Hum Genet 56: 67–74. Hornstra IK, Nelson DL, Warren ST, Yang TP. 1993. High resolution methylation analysis of the FMR1 gene trinucleotide repeat region in fragile X syndrome. Hum Mol Genet 2: 1659–1665. Howard PP, Friedman JM. 1985. Unaffected carrier males in families with fragile X syndrome. Am J Hum Genet 37: 956–964. Hwu, W-L, Lee, Y-M, Lee, S-C, Wang, T-R. 1993. In vitro DNA methylation inhibits FMR-1 promoter. Biochem Biophys Res Commun 193: 324–329. Kaufmann WE. 1996. Mental retardation and learning disabilities: A neuropathological differentiation. In: AJ Capute, PJ Accardo, editors. Developmental disabilities in infancy and childhood. Baltimore: Paul H. Brookes Publishing Co. p 49–70. Kaufmann WE, Abrams MT, Chen W, Reiss AL. 1997. Genotype and molecular phenotype in fragile X syndrome. Am J Hum Genet 61: 175. Khandjian EW, Fortin A, Thibodeau A, Tremblay S, Cote F, Devys D, Mandel JL, Rousseau F. 1995. A heterogeneous set of FMR1 proteins is widely distributed in mouse tissues and is modulated in cell culture. Hum Mol Genet 4: 783–789. Khandjian EW, Corbin F, Woerly S, Rousseau F. 1996. The fragile X menal retardation protein is associated with ribosomes. Nat Genet 12: 91–93. Kooy R, D'Hooge, R, Reyniers, E, Bakker, CE, Nagels, G, De Boulle, K, Storm, K, Clincke, G, De Deyn, PP, Oostra, BA, Willems, PJ. 1996. Transgenic mouse model for the fragile X syndrome. Am J Med Genet 64: 241–245. Krawczun MS, Jenkins EC, Brown WT. 1985. Analysis of the fragile-X chromosome: Localization and detection of the fragile site in high resolution preparations. Hum Genet 69: 209–211. Kremer EJ, Pritchard M, Lynch M, Yu S, Holman K, Baker E, Warren ST, Schlessinger D, Sutherland GR, Richards RI. 1991. Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CCG)n. Science 252: 1711–1714. Lachiewicz AM. 1992. Abnormal behaviors of young girls with fragile X syndrome. Am J Med Genet 43: 72–77. Lubs HA. 1969. A marker X-chromosome. Am J Hum Genet 21: 231–244. Lyford GL, Yamagata K, Kaufmann WE, Barnes CA, Sanders LK, Copeland NG, Gilbert DJ, Jenkins NA, Lanahan AA, Worley PF. 1995. Arc, a growth factor and activity-regulated gene encodes a novel cytoskeleton-associated protein that is enriched in neuronal dendrites. Neuron 13: 433–445. Martin JP, Bell J. 1943. A pedigree of mental defect showing sex-linkage. J Neurol Psychiatry 6: 154–157. Mazzocco MM, Hagerman RJ, Pennington BF. 1992. Problem solving limitations among cytogenetically expressing fragile X women. Am J Med Genet 43: 78–86. Mazzocco MM, Pennington BF, Hagerman RJ. 1993. The neurocognitive phenotype of female carriers of fragile X: Additional evidence for specificity. J Dev Behav Pediatr 14: 328–335. Mazzocco MM, Freund LF, Baumgardner TL, Reiss AL. 1995. Neuropsychological and psychosocial effects of the FMR-1 full mutation: Monozygotic twins discordant for the fragile X syndrome. Neuropsychology 9: 470–480. Meijer H, de Graaff, E, Merckx, DM, Jongbloed, RJ, de Die-Smulders, CE, Engelen, JJ, Fryns, JP, Curfs, PM, Oostra, BA. 1994. A deletion of 1.6 kb proximal to the CGG repeat of the FMR1 gene causes the clinical phenotype of the fragile X syndrome. Hum Mol Genet 3: 615–620. Morton NE, MacPherson JN. 1992. Population genetics of the fragile-X syndrome: Multiallelic model for the FMR1 locus. Proc Natl Acad Sci USA 89: 4215–4217. Nelson DL. 1996. Allelic expansion underlies many genetic diseases. Growth Genet Horm 12: 1–4. Nelson DL, Warren ST. 1993. Trinucleotide repeat instability: When and where? Nat Genet 4: 107–108. Neri G, Sanfilippo S, Pavone L,et al. 1988. The fragile X in Sicily: An epidemiological survey. Am J Med Genet 30: 665–672. Nolin SL, Glicksman A, Houck GJ, Brown WT, Dobkin CS. 1994. Mosaicism in fragile X affected males. Am J Med Genet 51: 509–512. Oberlé, I, Rousseau, F, Heitz, D, Kretz, C, Devys, D, Hanauer, A, Boue, J, Bertheas, MF, Mandel, JL. 1991. Instability of a 550 base pair DNA segment and abnormal methylation in fragile X syndrome. Science 252: 1097–1102. Oostra BA, Halley DJJ. 1995. Complex behavior of simple repeats: The fragile X syndrome. Pediatr Res 38: 629–637. Oostra BA, Hupkes PE, Perdon LF, Van Bennekom, CA, Bakker, E, Halley, DJ, Schmidt, M, Du Sart, D, Smits, A, Wieringa, B. 1990. New polymorphic DNA marker close to the fragile site FRAXA. Genomics 6: 129–132. Opitz JM, Sutherland GR. 1984. Conference report: International Workshop on the Fragile X and X-Linked Mental Retardation. Am J Med Genet 17: 5–94. Oudet C, Mornet E, Serre JL, Thomas F, Lentes-Zengerling, S, Kretz, C, Deluchat, C, Tejada, I, Boue, J, Boue, A, Mandel, JL. 1993. Linkage disequilibrium between the fragile X mutation and two closely linked CA repeats suggests that fragile X chromosomes are derived from a small number of founder chromosomes. Am J Hum Genet 52: 297–304. Pai GS, Sprenkle JA, Do TT, Mareni CE, Migeon BR. 1980. Localization of loci for hypoxanthine phosphoribosyltransferase and glucose-6 phosphate dehydrogenase and biochemical evidence of nonrandom X chromosome expression from studies of a human X-autosome translocation. Proc Natl Acad Sci USA 77: 2810–2813. Pembrey ME, Winter RM, Davies KE. 1985. A premutation that generates a defect at crossing over explains the inheritance of fragile X mental retardation. Am J Med Genet 21: 709–717. Pieretti M, Zhang FP, Fu YH, Warren ST, Oostra BA, Caskey CT, Nelson DL. 1991. Absence of expression of the FMR-1 gene in fragile X syndrome. Cell 66: 817–822. Reiss AL, Freund L. 1990. Fragile X syndrome, DSM-III-R and autism. J Am Acad Child Adolesc Psychiatry 29: 885–891. Reiss AL, Hagerman RJ, Vinogradov S, Abrams M, King RJ. 1988. Psychiatric disability in female carriers of the fragile X chromosome. Arch Gen Psychiatry 45: 25–30. Reiss AL, Aylward E, Freund LS, Joshi PK, Bryan RN. 1991a. Neuroanatomy of fragile X syndrome: The posterior fossa. Ann Neurol 29: 26–32. Reiss AL, Freund L, Tseng JE, Joshi PK. 1991b. Neuroanatomy in fragile X females: The posterior fossa. Am J Hum Genet 49: 279–288. Reiss AL, Freund L, Abrams MT, Boehm C, Kazazian H. 1993. Neurobehavioral effects of the fragile X premutation in adult women: A controlled study. Am J Hum Genet 52: 884–894. Reiss AL, Lee J, Freund L. 1994. Neuroanatomy of fragile X syndrome: The temporal lobe. Neurology 44: 1317–1324. Reiss AL, Abrams MT, Greenlaw R, Freund L, Denckla MB. 1995a. Neurodevelopmental effects of the FMR-1 full mutation in humans. Nat Med 1: 159–167. Reiss AL, Freund LF, Baumgardner TL, Abrams MT, Denckla MB. 1995b. Contribution of the FMR1 gene mutation to human intellectual dysfunction. Nat Genet 11: 331–334. Reyniers E, Vits L, De Boulle, K, Van Roy, B, Van Velzen, D, de Graaff, E, Verkerk, AJ, Jorens, HZ, Darby, JK, Oostra, B. 1993. The full mutation in the FMR-1 gene of male fragile X patients is absent in their sperm [see comments]. Nat Genet 4: 143–146. Ross C. 1995. When more is less: Pathogenesis of glutamine repeat neurodegenerative diseases. Neuron 15: 493–496. Rousseau F, Heitz D, Biancalana V, Blumenfeld S, Kretz C, Boue J, Tommerup N, Van Der Hagen, C, DeLozier-Blanchet, C, Croquette, MF, Gilgenkrantz, S, Jalbert, P, Voelckel, MA, Oberle, I, Mandel, JL. 1991. Direct diagnosis by DNA analysis of the fragile X syndrome of mental retardation. N Engl J Med 325: 1673–1681. Rousseau F, Heitz D, Tarleton J, MacPherson J, Malmgren H, Dahl N, Barnicoat A, Mathew C, Mornet E, Tejada I, Maddalena A, Spiegel R, Schinzel A, Marcos JAG, Schwartz C, Mandel JL. 1994. A multicenter study on genotype-phenotype correlations in the fragile X syndrome, using direct diagnosis with probe StB12.3: The first 2,253 cases. Am J Hum Genet 55: 225–237. Rudelli RD, Brown WT, Wisniewski K, Jenkins EC, Laure KM, Connell F, Wisniewski HM. 1985. Adult fragile X syndrome. Clinico-neuropathologic findings. Acta Neuropathol (Berl) 67: 289–295. Schapiro M, Murphy G, Hagerman RJ,et al. 1995. Adult fragile X syndrome: Neuropsychology, brain anatomy, and metabolism. Am J Med Genet 60: 480–493. Sherman SL, Morton NE, Jacobs PA, Turner G. 1984. The marker (X) syndrome: A cytogenetic and genetic analysis. Ann Hum Genet 48: 21–37. Sherman SL, Jacobs PA, Morton NE, Froster-Iskenius, U, Howard-Peebles, PN, Nielsen, KB, Partington, MW, Sutherland, GR, Turner, G, Watson, M. 1985. Further segregation analysis of the fragile X syndrome with special reference to transmitting males. Hum Genet 69: 289–299. Siomi H, Siomi MC, Nussbaum RL, Dreyfuss G. 1993. The protein product of the fragile X gene, FMR1, has characteristics of an RNA-binding protein. Cell 74: 291–298. Siomi H, Choi M, Siomi MC, Nussbaum RL, Dreyfuss G. 1994. Essential role for KH domains in RNA binding: Impaired RNA binding by a mutation in the KH domain of FMR1 that causes fragile X syndrome. Cell 77: 33–39. Siomi M, Siomi H, Sauer W, Srinivasan S, Nussbaum R, Dreyfuss G. 1995. FXR1, an autosomal homolog of the fragile X mental retardation gene. EMBO J 14: 291–298. Siomi M, Zhang Y, Siomi H, Dreyfuss G. 1996. Specific sequences in the fragile X syndrome protein FMR1 and the FXR proteins mediate their binding to 60S ribosomal subunits and the interactions among them. Mol Cell Biol 16: 3825–3832. Smits APT, Dreesen JCFM, Post JG, Smeets DFCM, de Die-Smulders, C, Spaans-van der Bijl, T, Govaerts, CP, Warren, ST, Oostra, BA, van Oost, B. 1993. The fragile X syndrome: No evidence for any recent mutations. J Med Genet 30: 94–96. Snow K, Doud LK, Hagerman R, Pergolizzi RG, Erster SH, Thibodeau SN. 1993. Analysis of a CGG sequence at the FMR-1 locus in fragile X families and in the general population. Am J Hum Genet 53: 1217–1228. Sobesky WE, Hull CE, Hagerman RJ. 1994. Symptoms of schizotypal personality disorder in fragile X women. J Am Acad Child Adolesc Psychiatry 33: 247–255. Steward O. 1995. Targeting of mRNAs to subsynaptic microdomains in dendrites. Curr Opin Neurobiol 5: 55–61. Sutcliffe JS, Nelson DL, Zhang F, Pieretti M, Caskey CT, Saxe D, Warren ST. 1992. DNA methylation represses FMR-1 transcription in fragile X syndrome. Hum Mol Genet 1: 397–400. Sutherland GR. 1977. Fragile sites on human chromosomes: Demonstration of their dependence on the type of tissue culture medium. Science 197: 265–266. Sutherland GR, Gedeon A, Kornman L, Donnelly A, Byard RW, Mulley JC, Kremer E, Lynch M, Pritchard M, Yu S. 1991. Prenatal diagnosis of fragile X syndrome by direct detection of the unstable DNA sequence. N Engl J Med 325: 1720–1722. Suthers GK, Hyland VJ, Callen DF,et al. 1990. Physical mapping of new DNA probes near the fragile X mutation (FRAXA) by using a panel of cell lines. Am J Hum Genet 47: 187–195. Tassone F, Hagerman RJ, Ikle D, Dyer PN, Lampe M, Willemsen R, Oostra BA, Taylor AK. 1997. FMRP expression as a potential prognostic indicator in fragile X syndrome. Am J Hum Genet 61: 321. Turner G, Eastman C, Casey J, McLeay A, Procopis P, Turner B. 1975. X-linked mental retardation associated with macro-orchidism. J Med Genet 12: 367–371. Van de Ouweland, AM, de Vries, BB, Bakker, PL, Deelen, WH, de Graaff, E, van Hemel, JO, Oostra, BA, Niermeijer, MF, Halley, DJ. 1994. DNA diagnosis of the fragile X syndrome in a series of 236 mentally retarded subjects and evidence for a reversal of mutation in the FMR-1 gene. Am J Med Genet 51: 482–485. Verheij C, Bakker CE, de Graaff, E, Keulemans, J, Willemsen, R, Verkerk, AJ, Galjaard, H, Reuser, AJ, Hoogeveen, AT, Oostra, BA. 1993. Characterization and localization of the FMR-1 gene product associated with fragile X syndrome. Nature 363: 722–724. Verheij C, de Graaff, E, Bakker, C, Willemsen, R, Willems, P, Meijer, N, Galjaard, H, Reuser, A, Oostra, B, Hoogeveen, A. 1995. Characterization of FMR1 proteins isolated from different tissues. Hum Mol Genet 4: 895–901. Verkerk AJMH, Pieretti M, Sutcliffe JS, Fu, Y-H, Kuhl, DPA, Pizzuti, A, Reiner, O, Richards, S, Victoria, MF, Zhang, F, Eussen, BE, van Ommen, G-JB, Blonden, LAJ, Riggins, GJ, Chastain, JL, Kunst, CB, Galjaard, H, Caskey, CT, Nelson, DL, Oostra, BA, Warren, ST. 1991. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65: 905–914. Verkerk AJMH, de Graaff, E, De Boulle, K, Eichler, EE, Konecki, DS, Reyniers, E, Manca, A, Poustka, A, Willems, PJ, Nelson, DL. 1993. Alternative splicing in the fragile X gene FMR1. Hum Mol Genet 2: 399–404. Vincent A, Heitz D, Petit C, Kretz C, Oberle I, Mandel JL. 1991. Abnormal pattern detected in fragile-X patients by pulsed-field gel electrophoresis. Nature 349: 624–626. Walton K, Rehfuss R. 1992. Molecular mechanisms of cAMP-regulated gene expression. Mol Neurobiol 3: 197–210. Warren ST, Ashley, CT Jr, 1995. Triplet repeat expansion mutations: The example of fragile X syndrome. Annu Rev Neurosci 18: 77–99. Warren ST, Nelson DL. 1994. Advances in molecular analysis of fragile X syndrome [see comments]. JAMA 271: 536–542. Warren ST, Zhang F, Licameli GR, Peters JF. 1987. The fragile X site in somatic cell hybrids: an approach for molecular cloning of fragile sites. Science 237: 420–423. Warren ST, Zhang FP, Sutcliffe JS, Peters JF. 1988. Strategy for molecular cloning of the fragile X site DNA. Am J Med Genet 30: 613–623. Warren ST, Knight SJL, Peters JF, Stayton CL, Consalez GG, Zhang FP. 1990. Isolation of the human chromosomal band Xq28 within somatic cell hybrids by fragile X site breakage. Proc Natl Acad Sci USA 87: 3856–3860. Webb TP, Bundey SE, Thake AI, Todd J. 1986. Population incidence and segregation ratios in the Martin-Bell syndrome. Am J Med Genet 23: 573–580. Weiler I, Irwin S, Klinstova AV, Spencer CM, Brazelton AD, Miyashiro K, Comery TA, Patel B, Eberwine J, Greenough WT. 1997. Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation. Proc Natl Acad Sci USA 94: 5395–5400. Willems PJ, Van Roy, B, De Boulle, K, Vits, L, Reyniers, E, Beck, O, Dumon, JE, Verkerk, A, Oostra, B. 1992. Segregation of the fragile X mutation from an affected male to his normal daughter. Hum Mol Genet 1: 511–517. Willemsen R, Mohkamsing S, DeVries B, Devys D, Van den Ouweland, A, Mandel, J, Gaijaard, H, Oostra, B. 1995. Rapid antibody test for fragile X syndrome. Lancet 345: 1147–1148. Wisniewski KE, French JH, Fernando S, Brown WT, Jenkins EC, Friedman E, Hill AL, Miezejeski CM. 1985. Fragile X syndrome: Associated neurological abnormalities and developmental disabilities. Ann Neurol 18: 665–669. Wöhrle, D, Kotzot, D, Hirst, MC,et al. 1992. A microdeletion of less than 250 kb, including the proximal part of the FMR-I gene and the fragile-X site, in a male with the clinical phenotype of fragile-X syndrome. Am J Hum Genet 51: 299–306. Wöhrle, D, Hennig, I, Vogel, W, Steinbach, P. 1993. Mitotic stability of fragile X mutations in differentiated cells indicates early post-conceptional trinucleotide repeat expansion. Nat Genet 4: 140–142. Wolozin B, Sunderland T, Zheng BB, Resau J, Dufy B, Barker J, Swerdlow R, Coon H. 1992. Continuous culture of neuronal cells from adult human olfactory epithelium. J Mol Neurosci 3: 137–146. Wolozin BL, Lesch KP, Lebovics RS, Sunderland T. 1993. Olfactory neuroblasts from Alzheimer donors: Studies on APP processing and cell regulation. Biol Psychiatry 34: 824–838. Yu S, Pritchard M, Kremer E, Lynch M, Nancarrow J, Baker E, Holman K, Mulley JC, Warren ST, Schlessinger D, Sutherland GR, Richards RI. 1991. Fragile X genotype characterized by an unstable region of DNA. Science 252: 1179–1181. Yu S, Mulley J, Loesch D, Turner G, Donnelly A, Gedeon A, Hillen D, Kremer E, Lynch M, Pritchard M, Sutherland GR, Richards RI. 1992. Fragile-X syndrome: Unique genetics of the heritable unstable element. Am J Hum Genet 50: 968–980. Zhang Y, O'Connor, JP, Siomi, MC, Srinivasan, S, Dutra, A, Nussbaum, RL, Dreyfuss, G. 1995. The fragile X mental retardation syndrome protein interacts with novel homologs FXR1 and FXR2. EMBO J 14: 5358–5366. Citing Literature Volume88, Issue15 February 1999Pages 11-24 ReferencesRelatedInformation
Referência(s)